LINDSAY HASSELWANDER: Open Payments
NPI 1306338017 · WESTWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$875 in 31 payments from 6 companies in 2025. Trend: 2023 $573 · 2024 $843 · 2025 $875
Food & beverage: $875
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 12 | $319 |
| ABBVIE INC. | 9 | $215 |
| AstraZeneca Pharmaceuticals LP | 3 | $172 |
| Eisai Inc. | 3 | $76 |
| Genmab U.S., Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $43 |
Products named: KEYTRUDA, LYNPARZA, ELAHERE, Lenvima, Tivdak, JEMPERLI.
Industry payments across KS — which companies pay providers there.
